ABOS
NASDAQ · Biotechnology
Acumen Pharmaceuticals Inc
$0.21
0.00 (-1.83%)
Analyst Consensus
Strong Sell
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+10,283.2% upside
Low Target
$18.81
Average Target
$22.22
High Target
$35.10
Current Price
$0.21
Current
$0.21
$0.21
Target
$22.22
$22.22
$18.81
$22.22 avg
$35.10
Scenario Analysis
Bear Case
$18.81
8,689.7%
Low target
Base Case
$22.22
+10,283.2%
Avg target
Bull Case
$35.10
+16,301.9%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$3.60
-94.1% from high
52-Week Low
$0.19
+12.0% from low
50-Day SMA
$1.90
-88.7% vs SMA
RSI (14)
17.2
Oversold
Target vs 52W High
$22.22
+517.2% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.7% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.8% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.6% |
| REGN | Buy | 36 | 72% | $76.80 | -92.0% |
| MRNA | Hold | 31 | 32% | $149.45 | -33.1% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.2% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -33.8% |